$136 Million is the total value of Fiera Capital (Europe) Ltd.'s 62 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 32.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AVHOQ | Sell | BAIDU INC ADRspon adr rep pfd | $24,549,000 | +1363.0% | 108,039 | -11.1% | 18.05% | +1390.4% |
PODD | Buy | ISHARE MSCI EMRG MKT | $21,452,000 | +11817.8% | 546,201 | +11120.2% | 15.77% | +12032.3% |
EEM | New | ITAU UNBANCO PRF ADRspon adr pref | $19,513,000 | – | 1,492,345 | +100.0% | 14.35% | – |
AGN | New | AMBEV SA NPV ADRsponsored adr | $7,509,000 | – | 1,150,999 | +100.0% | 5.52% | – |
BMRN | Buy | BRADESCO PREF ADRspon adr pref | $6,928,000 | +14333.3% | 515,289 | +77503.8% | 5.09% | +14454.3% |
BAP | Buy | FOMENTO ECONOMIC ADRcl a | $5,901,000 | +171.9% | 67,073 | +373.8% | 4.34% | +177.3% |
ITUB | Sell | JD.COM ADRspon adr | $5,548,000 | -73.1% | 239,613 | -83.8% | 4.08% | -72.5% |
BBD | Sell | BRASIL FOODS ADRspon adr | $4,820,000 | -35.1% | 205,558 | -60.4% | 3.54% | -33.8% |
SYK | Buy | TAL EDUCATION ADRspon adr | $4,760,000 | +5500.0% | 169,262 | +16066.4% | 3.50% | +5637.7% |
Sell | GRUPO TELEVISA ADR | $4,522,000 | +19.8% | 132,540 | -52.3% | 3.32% | +22.1% | |
CZZ | Sell | CREDICORP LTD | $4,362,000 | +814.5% | 27,273 | -38.7% | 3.21% | +832.3% |
CELG | Buy | CIA BRASILEIRA PREFsponsored adr | $3,750,000 | +2145.5% | 101,782 | +5696.2% | 2.76% | +2197.5% |
P103PS | Buy | PETROBRAS PREF ADRspon adr pref | $3,246,000 | +3588.6% | 426,250 | +12639.1% | 2.39% | +3688.9% |
JNJ | Buy | LUXOFT HOLDING INC | $2,785,000 | +287.9% | 72,245 | +975.4% | 2.05% | +295.4% |
GRAM | Buy | GRUPO AVAL ADRspon adr | $2,492,000 | +8.4% | 240,270 | +56.6% | 1.83% | +10.5% |
CBD | Sell | COPA HOLDINGS SA Asponsored adr | $1,980,000 | -48.2% | 19,072 | -78.2% | 1.46% | -47.2% |
GILD | Buy | GRANA Y MONTERO ADRspon adr | $1,939,000 | +353.0% | 153,467 | +3717.6% | 1.43% | +361.5% |
TMO | Buy | ULTRAPAR ADRspon adr | $1,716,000 | +594.7% | 89,622 | +4336.7% | 1.26% | +609.0% |
AMPH | New | AVIANCA HOLDINGS ADRspon adr rep pfd | $1,426,000 | – | 121,576 | +100.0% | 1.05% | – |
JD | Sell | JOHNSON & JOHNSON | $609,000 | -88.8% | 5,800 | -97.3% | 0.45% | -88.6% |
PBRA | Sell | PFIZER INC | $579,000 | -96.9% | 18,533 | -98.5% | 0.43% | -96.9% |
UGP | Sell | VALE S.A. ON ADRspon adr | $514,000 | -72.8% | 62,690 | -30.1% | 0.38% | -72.3% |
MDVN | Buy | MERCK & CO INC | $419,000 | +84.6% | 7,362 | +220.9% | 0.31% | +87.8% |
ABBV | ABBVIE INC | $349,000 | +12.9% | 5,332 | 0.0% | 0.26% | +15.2% | |
CPA | Buy | COSAN LTD CLASS A | $346,000 | -84.0% | 44,520 | +121.1% | 0.25% | -83.7% |
MRK | Sell | MYLAN INC | $289,000 | -34.0% | 5,115 | -30.5% | 0.21% | -32.9% |
GHDX | Buy | GILEAD SCIENCES INC | $287,000 | +635.9% | 3,035 | +119.9% | 0.21% | +653.6% |
BRFS | Sell | BRISTOL MYERS SQUIBBsp adr pfd new | $262,000 | -94.1% | 4,427 | -97.6% | 0.19% | -94.0% |
TAL | Sell | THERMO FISHER | $254,000 | -95.7% | 2,020 | -98.8% | 0.19% | -95.6% |
ABT | ABBOTT LABS | $231,000 | +8.5% | 5,110 | 0.0% | 0.17% | +10.4% | |
NSTG | Buy | NPS PHARMACEUTICALS | $229,000 | +408.9% | 6,389 | +56.6% | 0.17% | +425.0% |
INCY | Buy | INSULET CORP | $224,000 | +489.5% | 4,868 | +533.0% | 0.16% | +511.1% |
AEGR | New | AEGERION PHARMA | $202,000 | – | 9,641 | +100.0% | 0.15% | – |
BMY | Sell | CELGENE CORPsp adr pfd new | $197,000 | -13.2% | 1,756 | -60.3% | 0.14% | -11.6% |
REGN | Buy | SALIX PHARMACEUTICAL | $182,000 | +378.9% | 1,569 | +1394.3% | 0.13% | +396.3% |
TV | Sell | ILLUMINA INC | $175,000 | -96.3% | 948 | -99.3% | 0.13% | -96.2% |
ABEV | Sell | AMGEN INCsponsored adr | $156,000 | -97.8% | 978 | -99.9% | 0.12% | -97.8% |
BIDU | Sell | BECTON DICKINSONspon adr rep a | $146,000 | -99.4% | 1,050 | -99.0% | 0.11% | -99.4% |
PFE | Sell | PHARMACYCLICS INC | $143,000 | -74.0% | 1,168 | -93.7% | 0.10% | -73.6% |
MBT | New | MEDIVATION INC | $142,000 | – | 1,420 | +100.0% | 0.10% | – |
Q | Sell | REGENERON PHARMA | $140,000 | +159.3% | 341 | -65.0% | 0.10% | +164.1% |
IPXL | Sell | INCYTE CORPspon adr units | $104,000 | +52.9% | 1,426 | -50.2% | 0.08% | +55.1% |
MYL | Buy | NANOSTRING TECH | $103,000 | -56.0% | 7,451 | +45.7% | 0.08% | -55.0% |
SLXP | Sell | STRYKER CORP | $99,000 | -47.3% | 1,047 | -12.5% | 0.07% | -46.3% |
AMGN | Buy | AMPHASTAR PHARMA | $98,000 | +3.2% | 8,451 | +1152.0% | 0.07% | +4.3% |
ILMN | Buy | IMPAX LABORATORIESspon adr units | $91,000 | -41.7% | 2,865 | +202.2% | 0.07% | -40.7% |
BDX | Sell | BIOGEN IDEC INC | $80,000 | -33.3% | 236 | -77.5% | 0.06% | -32.2% |
BIIB | Buy | BIOMARIN PHARMA | $60,000 | -23.1% | 664 | +181.4% | 0.04% | -21.4% |
PCYC | Buy | QUINTILES TRANS | $58,000 | -47.3% | 973 | +3.8% | 0.04% | -45.6% |
FMX | Sell | GENOMIC HEALTH INCcl a | $44,000 | -99.3% | 1,380 | -97.9% | 0.03% | -99.3% |
MDCO | Exit | MEDICINES CO | $0 | – | -970 | -100.0% | -0.02% | – |
BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -2,262 | -100.0% | -0.02% | – |
CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -612 | -100.0% | -0.03% | – |
THRX | Exit | THERAVANCE INC | $0 | – | -4,532 | -100.0% | -0.06% | – |
TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -4,340 | -100.0% | -0.07% | – |
Exit | ALLERGAN INC | $0 | – | -830 | -100.0% | -0.11% | – | |
OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -35,200 | -100.0% | -0.11% | – |
SNY | Exit | SANOFIsponsored adr | $0 | – | -2,700 | -100.0% | -0.11% | – |
MDT | Exit | MEDTRONIC INC | $0 | – | -2,718 | -100.0% | -0.12% | – |
BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -5,000 | -100.0% | -0.32% | – |
PBR | Exit | PETROLEO BRASILEIRO SA PETROsponsored adr | $0 | – | -39,657 | -100.0% | -0.40% | – |
Exit | CREDICORP LTD | $0 | – | -14,517 | -100.0% | -1.60% | – | |
VNET | Exit | 21VIANET GROUP INCsponsored adr | $0 | – | -176,285 | -100.0% | -2.29% | – |
VALE | Exit | VALE S Aadr | $0 | – | -338,040 | -100.0% | -2.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
JD.COM ADR | 16 | Q1 2017 | 18.4% |
GENOMIC HEALTH INC | 16 | Q1 2017 | 9.1% |
PFIZER INC | 16 | Q1 2017 | 13.5% |
FOMENTO ECONOMIC ADR | 16 | Q1 2017 | 5.1% |
BRISTOL MYERS SQUIBB | 16 | Q1 2017 | 4.8% |
BECTON DICKINSON | 15 | Q1 2017 | 21.4% |
AMGEN INC | 14 | Q1 2017 | 9.3% |
BRASIL FOODS ADR | 14 | Q1 2017 | 8.1% |
VALE S A | 14 | Q1 2017 | 13.5% |
PHARMACYCLICS INC | 14 | Q1 2017 | 0.8% |
View Fiera Capital (Europe) Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-NT | 2024-02-13 |
13F-NT | 2023-11-02 |
13F-NT | 2023-08-08 |
13F-NT | 2023-05-09 |
13F-NT | 2023-02-13 |
13F-NT | 2022-11-14 |
13F-NT | 2022-08-09 |
13F-NT | 2022-05-16 |
13F-NT | 2022-02-11 |
13F-NT | 2021-11-12 |
View Fiera Capital (Europe) Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.